Cardium Therapeutics, an asset-based health sciences and regenerative medicine company, is scheduled to present a poster demonstrating the clinical benefits of its lead commercial product, Excellagen®, at The Symposium on Advanced Wound Care and Wound Healing Society (SAWC/WHS) meeting to be held May 1-5, 2013, in Denver, Colorado.
Authored by Steven Smith, M.D., Mohs surgeon, of Wellesley, Mass, the presentation titled “Accelerated Granulation and Healing of Problematic Post-Surgical Wounds with Formulated Collagen Gel 2.6%” will be presented by Lois Chandler, Ph.D., Cardium’s vice president of Biologics Development.
As an advanced regenerative wound product, Excellagen is capable of promoting rapid granulation and complete healing in three difficult and complex post-surgical wounds, including Mohs surgery and wound dehiscence. The presentation highlights these capabilities and presents the case that Excellagen has eliminated the need for expensive secondary reconstruction and/or skilled nursing care.
The 2013 Spring SAWC/WHS meeting gives Cardium the opportunity to exhibit Excellagen’s capabilities to more than 2,000 attendees, including physicians, podiatrists, nurses, therapists, and researchers who specialize in wound management.
The poster presentation can be viewed at www.excellagen.com/meetings-and-publications.html.
For more information visit www.cardiumthx.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment